Hap Trading, LLC Adaptive Biotechnologies Corp Call Options Transaction History

Hap Trading, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $2.51 Million - $3.75 Million	401,000 New	401,000 $270,000
Q1 2021 May 14, 2021	SELL	$37.26 - $67.74 $536,544 - $975,455	-14,400 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $648,144 - $942,768	14,400 New	14,400 $120,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.